1. Home
  2. KLTOW vs GRRRW Comparison

KLTOW vs GRRRW Comparison

Compare KLTOW & GRRRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • GRRRW
  • Stock Information
  • Founded
  • KLTOW N/A
  • GRRRW N/A
  • Country
  • KLTOW United States
  • GRRRW United Kingdom
  • Employees
  • KLTOW 3
  • GRRRW 143
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • GRRRW Computer Software: Prepackaged Software
  • Sector
  • KLTOW Health Care
  • GRRRW Technology
  • Exchange
  • KLTOW Nasdaq
  • GRRRW Nasdaq
  • Market Cap
  • KLTOW N/A
  • GRRRW N/A
  • IPO Year
  • KLTOW 2022
  • GRRRW N/A
  • Fundamental
  • Price
  • KLTOW $0.18
  • GRRRW $0.45
  • Analyst Decision
  • KLTOW
  • GRRRW
  • Analyst Count
  • KLTOW 0
  • GRRRW 0
  • Target Price
  • KLTOW N/A
  • GRRRW N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • GRRRW 336.7K
  • Earning Date
  • KLTOW N/A
  • GRRRW 04-04-2025
  • Dividend Yield
  • KLTOW N/A
  • GRRRW N/A
  • EPS Growth
  • KLTOW N/A
  • GRRRW N/A
  • EPS
  • KLTOW N/A
  • GRRRW 2.28
  • Revenue
  • KLTOW N/A
  • GRRRW $78,940,347.00
  • Revenue This Year
  • KLTOW N/A
  • GRRRW N/A
  • Revenue Next Year
  • KLTOW N/A
  • GRRRW N/A
  • P/E Ratio
  • KLTOW N/A
  • GRRRW $25.04
  • Revenue Growth
  • KLTOW N/A
  • GRRRW 424.97
  • 52 Week Low
  • KLTOW N/A
  • GRRRW $1.06
  • 52 Week High
  • KLTOW N/A
  • GRRRW $1.54
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • GRRRW N/A
  • Support Level
  • KLTOW N/A
  • GRRRW N/A
  • Resistance Level
  • KLTOW N/A
  • GRRRW N/A
  • Average True Range (ATR)
  • KLTOW 0.00
  • GRRRW 0.00
  • MACD
  • KLTOW 0.00
  • GRRRW 0.00
  • Stochastic Oscillator
  • KLTOW 0.00
  • GRRRW 0.00

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About GRRRW Gorilla Technology Group Inc. Warrant

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: